AU2003273856A8 - Vr1 antagonists for the treatment of urological disorders - Google Patents

Vr1 antagonists for the treatment of urological disorders

Info

Publication number
AU2003273856A8
AU2003273856A8 AU2003273856A AU2003273856A AU2003273856A8 AU 2003273856 A8 AU2003273856 A8 AU 2003273856A8 AU 2003273856 A AU2003273856 A AU 2003273856A AU 2003273856 A AU2003273856 A AU 2003273856A AU 2003273856 A8 AU2003273856 A8 AU 2003273856A8
Authority
AU
Australia
Prior art keywords
antagonists
treatment
urological disorders
urological
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273856A
Other versions
AU2003273856A1 (en
Inventor
Masahiro Shiroo
Noriyuki Yamamoto
Masomi Tajimi
Yasuhiro Tsukimi
Takeshi Yura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003273856A8 publication Critical patent/AU2003273856A8/en
Publication of AU2003273856A1 publication Critical patent/AU2003273856A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003273856A 2002-09-24 2003-09-11 Vr1 antagonists for the treatment of urological disorders Abandoned AU2003273856A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02021367 2002-09-24
EP02021367.4 2002-09-24
PCT/EP2003/010111 WO2004028440A2 (en) 2002-09-24 2003-09-11 Vr1 antagonists for the treatment of urological disorders

Publications (2)

Publication Number Publication Date
AU2003273856A8 true AU2003273856A8 (en) 2004-04-19
AU2003273856A1 AU2003273856A1 (en) 2004-04-19

Family

ID=32039089

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273856A Abandoned AU2003273856A1 (en) 2002-09-24 2003-09-11 Vr1 antagonists for the treatment of urological disorders

Country Status (2)

Country Link
AU (1) AU2003273856A1 (en)
WO (1) WO2004028440A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004055004A1 (en) 2002-12-13 2004-07-01 Neurogen Corporation Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
JP2007534624A (en) 2003-07-16 2007-11-29 ニューロジェン・コーポレーション Biaryl piperazinyl-pyridine analogues
WO2005035471A1 (en) 2003-10-14 2005-04-21 Ajinomoto Co., Inc. Ether derivative
AU2007288203B2 (en) 2006-08-23 2013-01-17 Neurogen Corporation 2-phenoxy pyrimidinone analogues
US8128591B2 (en) 2008-11-10 2012-03-06 Warsaw Orthopedic, Inc. Multiple component mixing and delivery system
DE102022104759A1 (en) 2022-02-28 2023-08-31 SCi Kontor GmbH Co-crystal screening method, in particular for the production of co-crystals

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630515B2 (en) * 1997-08-28 2003-10-07 Afferon Corporation Urinary incontinence therapy
GB9826359D0 (en) * 1998-12-01 1999-01-27 Glaxo Group Ltd Novel receptors
NZ523526A (en) * 2000-07-20 2004-10-29 Neurogen Corp Diaryl piperazines as capsaicin receptor ligands
AU8022901A (en) * 2000-08-21 2002-03-04 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
GB0105895D0 (en) * 2001-03-09 2001-04-25 Smithkline Beecham Plc Novel compounds
US20040259875A1 (en) * 2001-07-31 2004-12-23 Takeshi Yura Amine derivatives
JP2003192587A (en) * 2001-12-26 2003-07-09 Bayer Ag Urea derivative
RU2331635C2 (en) * 2002-05-08 2008-08-20 Байер ХельсКер АГ Hydroxy-tetrahydro-naphthalenyl-urea derivatives

Also Published As

Publication number Publication date
WO2004028440A3 (en) 2004-07-15
AU2003273856A1 (en) 2004-04-19
WO2004028440A2 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
HK1091732A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
PL372425A1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
AU2003286567A8 (en) Methods for the treatment of skin disorders
ZA200401004B (en) Combination for the treatment of inflammatory disorders
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003274342A8 (en) Compositions for the treatment of autoimmune disorders
PL1656346T3 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
IL175055A0 (en) Combinations useful for the treatment of neuronal disorders
IL161041A0 (en) Mch antagonists for the treatment of obesity
PT1530466E (en) Use of nintedanib for the treatment of lung fibrosis
AU2003228819A8 (en) Combinations for the treatment of inflammatory skin disorders
AU2003286728A8 (en) Compounds for the treatment of metabolic disorders
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
IL157145A0 (en) Use of dc23 antagonists for the treatment of neoplastic disorders
AU2003290059A8 (en) Use of cd137 antagonists for the treatment of tumors
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003273856A8 (en) Vr1 antagonists for the treatment of urological disorders
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
GB0201025D0 (en) The treatment of degenerative diseases
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
HRP20041159A2 (en) Combination for the treatment of airway disorders
AU2003245995A8 (en) Use of gaba-c receptor antagonists for the treatment of myopia
ZA200508341B (en) Agents for the treatment of lower abdominal disorders
GB0317241D0 (en) Therapeutic agents for the treatment of bone disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase